Skip to main content
. 2010 Aug 1;33(8):1069–1074. doi: 10.1093/sleep/33.8.1069

Table 1.

Demographic, clinical characteristics, snoring and risk of OSA of the study populationa

Factor PE
OR (95%CI) P-value
Positive (n = 71) Negative (n = 199)
    Demographics
        Age, y 60.0 ± 15.7 61.3 ± 17.2 0.96 (0.81,1.12) 0.58
        Men 43 (61) 73 (37) 2.65 (1.52,4.62) 0.001
        Weight, kg 86.1 ± 23.6 78.0 ± 20.3 1.18 (1.04,1.34) 0.008
        BMI, kg/m2 28.7 ± 7.0 27.9 ± 6.7 1.02 (0.98, 1.06) 0.38
    Clinical Characteristics
        PE risk factors
            Hereditarya 10 (14) 6 (3) 5.27 (1.84, 15.10) 0.002
            Acquiredb 53 (75) 128 (64) 1.63 (0.89, 3.00) 0.11
            Hypertension 31 (44) 106 (53) 0.68 (0.39, 1.17) 0.17
            CHF 4 (6) 30 (15) 0.34 (0.11, 0.99) 0.048
            MI 4 (6) 19 (10) 0.57 (0.19, 1.72) 0.32
            Smoking 13 (18) 39 (20) 0.92 (0.46, 1.84) 0.81
            Pacemaker/central line 10 (14) 16 (8) 1.88 (0.81, 4.35) 0.14
            IBD 2 (3) 3 (2) 1.89 (0.31, 11.57) 0.49
            Nephrotic syndrome 0 (0) 3 (2) N/A 1.00
    Snoring and risk of OSA
        Snoring 53 (75) 100 (50) 2.91 (1.60, 5.33) 0.001
        Risk of OSA 46 (65) 72 (36) 3.25 (1.84, 5.72) <0.001

Data are shown as mean ± SD or number (%). OR refers to odds ratio from univariate logistic regression analyses for pulmonary embolism (PE); OSA, obstructive sleep apnea; CI, confidence interval; BMI, body mass index; CHF, congestive heart failure; MI, myocardial infarction; IBD, inflammatory bowel disease.

a

Family history of deep vein thrombosis (DVT) or PE.

b

Personal history of DVT/PE, oral contraceptive use, pregnancy, malignancy, immobility, trauma, fractures, spinal cord injury, surgery, or varicose veins.